Literature DB >> 15175136

Hereditary angioedema: the rewards of studying a rare disease.

Michael M Frank1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15175136     DOI： 10.1007/s11882-004-0064-7

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN： 1529-7322            Impact factor:   4.919


× No keyword cloud information.
  17 in total

1.  Hereditary angioedema: the clinical syndrome and its management.

Authors:  M M Frank; J A Gelfand; J P Atkinson
Journal:  Ann Intern Med       Date:  1976-05       Impact factor: 25.391

2.  Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein.

Authors:  N S LANDERMAN; M E WEBSTER; E L BECKER; H E RATCLIFFE
Journal:  J Allergy       Date:  1962 Jul-Aug

3.  Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study.

Authors:  M M Frank; J S Sergent; M A Kane; D W Alling
Journal:  N Engl J Med       Date:  1972-04-13       Impact factor: 91.245

4.  Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor.

Authors:  Eun D Han; Ryan C MacFarlane; Aideen N Mulligan; Jennifer Scafidi; Alvin E Davis
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

5.  Hereditary angioedema with normal C1-inhibitor activity in women.

Authors:  K Bork; S E Barnstedt; P Koch; H Traupe
Journal:  Lancet       Date:  2000-07-15       Impact factor: 79.321

6.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities.

Authors:  J A Gelfand; R J Sherins; D W Alling; M M Frank
Journal:  N Engl J Med       Date:  1976-12-23       Impact factor: 91.245

7.  Acquired C1 inhibitor (C1-INH) deficiency type II. Replacement therapy with C1-INH and analysis of patients' C1-INH and anti-C1-INH autoantibodies.

Authors:  J Alsenz; J D Lambris; K Bork; M Loos
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

8.  Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion.

Authors:  Shenghe Cai; Alvin E Davis
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

9.  C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide.

Authors:  Dongxu Liu; Shenghe Cai; Xiaogang Gu; Jennifer Scafidi; Xiao Wu; Alvin E Davis
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

10.  Complement 1 inhibitor is a regulator of the alternative complement pathway.

Authors:  H Jiang; E Wagner; H Zhang; M M Frank
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.